52 related articles for article (PubMed ID: 15030340)
21. Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma.
Duvic M; Martin AG; Kim Y; Olsen E; Wood GS; Crowley CA; Yocum RC;
Arch Dermatol; 2001 May; 137(5):581-93. PubMed ID: 11346336
[TBL] [Abstract][Full Text] [Related]
22. Phase II clinical trial of bexarotene gel 1% in psoriasis.
Breneman D; Sheth P; Berger V; Naini V; Stevens V
J Drugs Dermatol; 2007 May; 6(5):501-6. PubMed ID: 17679184
[TBL] [Abstract][Full Text] [Related]
23. The efficacy of '0.05% Clobetasol + 2.5% zinc sulphate' cream vs. '0.05% Clobetasol alone' cream in the treatment of the chronic hand eczema: a double-blind study.
Faghihi G; Iraji F; Shahingohar A; Saidat A
J Eur Acad Dermatol Venereol; 2008 May; 22(5):531-6. PubMed ID: 18284511
[TBL] [Abstract][Full Text] [Related]
24. An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema.
Weatherhead SC; Wahie S; Reynolds NJ; Meggitt SJ
Br J Dermatol; 2007 Feb; 156(2):346-51. PubMed ID: 17223876
[TBL] [Abstract][Full Text] [Related]
25. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
[TBL] [Abstract][Full Text] [Related]
26. Novel treatment of chronic severe hand dermatitis with bexarotene gel.
Hanifin JM; Stevens V; Sheth P; Breneman D
Br J Dermatol; 2004 Mar; 150(3):545-53. PubMed ID: 15030340
[TBL] [Abstract][Full Text] [Related]
27. Bexarotene gel: a new skin-directed treatment option for cutaneous T-cell lymphomas.
Martin AG
J Drugs Dermatol; 2003 Apr; 2(2):155-67. PubMed ID: 12852367
[TBL] [Abstract][Full Text] [Related]
28. Emerging role of rexinoids in non-small cell lung cancer: focus on bexarotene.
Rigas JR; Dragnev KH
Oncologist; 2005 Jan; 10(1):22-33. PubMed ID: 15632250
[TBL] [Abstract][Full Text] [Related]
29. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis.
Hebert AA
Clin Ther; 2006 Dec; 28(12):1972-82. PubMed ID: 17296454
[TBL] [Abstract][Full Text] [Related]
30. The role of topical calcineurin inhibitors in atopic dermatitis.
Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
[TBL] [Abstract][Full Text] [Related]
31. The optimal use of bexarotene in cutaneous T-cell lymphoma.
Gniadecki R; Assaf C; Bagot M; Dummer R; Duvic M; Knobler R; Ranki A; Schwandt P; Whittaker S
Br J Dermatol; 2007 Sep; 157(3):433-40. PubMed ID: 17553039
[TBL] [Abstract][Full Text] [Related]
32. U.K. consensus statement on safe clinical prescribing of bexarotene for patients with cutaneous T-cell lymphoma.
Scarisbrick JJ; Morris S; Azurdia R; Illidge T; Parry E; Graham-Brown R; Cowan R; Gallop-Evans E; Wachsmuth R; Eagle M; Wierzbicki AS; Soran H; Whittaker S; Wain EM
Br J Dermatol; 2013 Jan; 168(1):192-200. PubMed ID: 22963233
[TBL] [Abstract][Full Text] [Related]
33. Current and emerging therapies for hand eczema.
Lee GR; Maarouf M; Hendricks AK; Lee DE; Shi VY
Dermatol Ther; 2019 May; 32(3):e12840. PubMed ID: 30693618
[TBL] [Abstract][Full Text] [Related]
34. Oral alitretinoin: a review of the clinical pharmacokinetics and pharmacodynamics.
Schmitt-Hoffmann AH; Roos B; Schoetzau A; Leese PT; Meyer I; van de Wetering J; Kovacs P
Expert Rev Clin Pharmacol; 2012 Jul; 5(4):373-88. PubMed ID: 22943117
[TBL] [Abstract][Full Text] [Related]
35. [Management of chronic hand eczema].
Lahfa M
Ann Dermatol Venereol; 2014 Jun; 141 Suppl 1():S143-50. PubMed ID: 24953623
[TBL] [Abstract][Full Text] [Related]
36. [How I treat...the dry skin of the hands].
Xhauflaire-Uhoda E; Piérard GE
Rev Med Liege; 2007 Mar; 62(3):129-31. PubMed ID: 17511376
[TBL] [Abstract][Full Text] [Related]
37. Alitretinoin: A Review in Severe Chronic Hand Eczema.
Blair HA; Scott LJ
Drugs; 2016 Sep; 76(13):1271-1279. PubMed ID: 27438290
[TBL] [Abstract][Full Text] [Related]
38. [Off-label use of alitretinoin].
Fritz K; Tiplica GS; Salavastru C; Onder M
Hautarzt; 2013 Oct; 64(10):748-51. PubMed ID: 24150823
[TBL] [Abstract][Full Text] [Related]
39. Hand dermatitis: a review of clinical features, prevention and treatment.
Antonov D; Schliemann S; Elsner P
Am J Clin Dermatol; 2015 Aug; 16(4):257-270. PubMed ID: 25920436
[TBL] [Abstract][Full Text] [Related]
40. [Chronic hand eczema: epidemiology and therapeutic evidence].
Diepgen TL
Hautarzt; 2008 Sep; 59(9):683-4, 686-9. PubMed ID: 18709342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
